Raymond James analyst John Ransom downgraded Accolade (ACCD) to Market Perform from Outperform without a price target after the company signed a definitive agreement to be acquired by Transcarent for $7.03 per share and a $621M equity value in an all-cash transaction. The firm thinks the deal makes “rational sense” given Accolade’s trading action and “depressed valuation” before the news.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACCD: